Retinal organoids, the three-dimensional tissues coaxed from stem cells that self-organize into layered, light-sensitive structures, have become one of the most celebrated tools in modern vision science. They allow researchers to study retinal development and inherited blindness without experimenting on animals, and they can be produced in large batches from a single starting culture. But most assessments of how faithfully organoids replicate the native retina have relied on RNA sequencing and proteomics, techniques that measure molecular blueprints rather than the actual chemistry of life. Genes can be switched on without the corresponding metabolic machinery running at full tilt, and proteins can be present without the small molecules they process flowing through pathways at realistic rates.

To close that gap, the team led by first author Pragati Gupta turned to untargeted metabolomics, a technique that captures the small molecules, sugars, amino acids, and lipids that represent the working currency of cellular metabolism. Using gas chromatography coupled to mass spectrometry, they compared the intracellular metabolite profiles of mouse retinal organoids at day 28 of differentiation with retinas dissected from three-day-old C57BL/6 mice. The choice of comparison points was deliberate: previous transcriptomic work had shown that day-28 organoids most closely resemble early postnatal retinal development, making the P3 retina the fairest developmental benchmark available.

The results were striking in their overall overlap. Of 166 annotated compounds detected across the study, 148 were shared between organoids and native retina, spanning amino acids and their derivatives, lipids and fatty acids, carbohydrates and sugar alcohols, and organic acids. Crucially, the conserved metabolites included the chemical heavyweights of retinal function: glutamate and gamma-aminobutyric acid, the central mediators of retinal neurotransmission; taurine, one of the most abundant metabolites in the vertebrate retina and essential for photoreceptor survival; and the TCA cycle intermediates citrate, succinate, fumarate, and malate that power the cell’s energy factories. The organoids, in other words, had built a genuinely retina-like biochemical identity rather than becoming some metabolically generic blob of tissue.

But the devil, as always, was in the differences. When the researchers applied stringent statistical thresholds, requiring a false discovery rate below 0.05 and a fold change of at least tenfold in either direction, a pattern of selective metabolic immaturity emerged. Several metabolites central to central carbon metabolism were abundant in native retina but fell below detection in organoids, including glucose-6-phosphate, a gateway metabolite of glycolysis; ribulose-5-phosphate, a signature intermediate of the pentose phosphate pathway; glycerol-3-phosphate and dihydroxyacetone phosphate, which link sugar metabolism to lipid synthesis; and phosphoethanolamine and myo-inositol, both tied to membrane phospholipid metabolism. TCA cycle-associated compounds including citric, fumaric, and oxalic acid also showed altered abundance between the two tissues.

Pathway enrichment analysis sharpened the picture further, identifying significant alterations in alanine, aspartate, and glutamate metabolism, along with changes in arginine biosynthesis, glycine, serine, and threonine metabolism, taurine and hypotaurine metabolism, and starch and sucrose metabolism. Multivariate statistics told the same story from a different angle. Principal component analysis and partial least squares discriminant analysis both separated organoids from native retina cleanly, with metabolites such as pantothenic acid, erythritol, phosphate, and glycerol-3-phosphate ranking among the strongest drivers of the distinction. Metabolites including urea, erythritol, phosphoethanolamine, and pyroglutamic acid pointed toward the native retina cluster, while fructofuranose, galactopyranose, and modified galactose derivatives pointed toward the organoids.

The team also tracked what the growing organoids ate and excreted, by analyzing the conditioned culture media collected longitudinally between day 8 and day 28 of differentiation. Here, the data revealed clear stage-dependent remodeling: early, intermediate, and late media samples each formed distinct clusters in multivariate space, with amino acid-associated and carbohydrate-associated metabolites showing the most pronounced temporal shifts. Notably, extracellular glutamate and glycine changed in abundance as the organoids matured, a finding consistent with earlier reports that developing retinal tissue actively consumes glutamate and aspartate. This supports an emerging concept in vision science of the retina as a metabolic ecosystem, in which photoreceptors, Müller glia, and the retinal pigment epithelium exchange lactate, nutrients, and antioxidants in a tightly choreographed economy.

Why does this matter beyond the laboratory bench? The retina’s extraordinary metabolic demands make it uniquely vulnerable to metabolic failure, and defects in energy metabolism are increasingly implicated in inherited retinal degenerations, diabetic retinopathy, and age-related macular degeneration. If organoids are to serve as faithful models of these diseases, or as testing grounds for gene therapies and cell transplants, their metabolic fidelity becomes a critical quality metric. The new findings suggest that current culture conditions produce organoids with the right metabolic vocabulary but an incomplete fluency: the core retinal metabolites are present, yet the energy-generating and biosynthetic pathways that support mature photoreceptor function have not fully caught up with the native tissue.

The authors are careful to frame their conclusions within the study’s limitations. Metabolomics by gas chromatography measures relative abundance rather than metabolic flux, so a metabolite absent from the organoid signal is not necessarily absent from the organoid itself; it may simply fall below the detection threshold or be lost during extraction and derivatization. The technique is also relatively blind to complex lipids, retinoids, and low-abundance signaling molecules, precisely the classes that matter for photoreceptor outer segments. The comparison captures a single developmental snapshot rather than a longitudinal trajectory, and some differences may reflect developmental asynchrony between a dish and a living eye rather than intrinsic organoid deficiencies. The organoids also lack the retinal pigment epithelium interaction and vascular nutrient exchange that shape retinal metabolism in vivo, and the conditioned media changes may partly reflect stage-specific culture supplements rather than biology alone.

Even so, the study delivers a practical roadmap. The specific metabolic gaps it identifies, in glycolysis, the pentose phosphate pathway, phospholipid metabolism, and amino acid neurotransmitter cycling, point directly to candidate interventions: adjusted nutrient compositions, improved oxygenation, co-culture with retinal pigment epithelium, and lipid or antioxidant supplementation of the kind already shown to improve photoreceptor outer segment development in earlier organoid studies. The authors also emphasize that their mouse organoid system, which matures in roughly 28 days compared with around 200 days for human retinal organoids, offers a fast, cost-effective platform aligned with the 3R principles of replacing, reducing, and refining animal use. Future work combining metabolomics with isotope tracing and functional assays should reveal whether these metabolic differences represent delayed maturation that culture optimization can fix, or a more fundamental ceiling of the dish-bound retina. Either way, the message is clear: to build a better retina in a dish, scientists must now feed it not just growth factors, but the right chemistry.

Subject of Research: Metabolomic comparison of stem cell-derived mouse retinal organoids and native mouse retina

Article Title: Metabolic profiling of retinal organoids reveals conserved core metabolites and alterations in glycolytic and amino acid metabolism

Article References: Gupta, P., Wiesner, C., Ziemssen, F., Klevering, J., Kulkarini, P., & Hosseinzadeh, Z. (2026). Metabolic profiling of retinal organoids reveals conserved core metabolites and alterations in glycolytic and amino acid metabolism. Metabolomics, 22(6), Article 171. https://doi.org/10.1007/s11306-026-02523-4

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02523-4

Keywords: retinal organoids, metabolomics, mouse retina, GC-MS, glycolysis, TCA cycle, amino acid metabolism, photoreceptors, taurine, glutamate, pentose phosphate pathway, stem cell models

Aldolase catalyzes the fourth step of glycolysis, cleaving fructose-1,6-bisphosphate into two three-carbon sugars, glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Because these triose phosphates feed both the lower half of glycolysis and the glycerol backbone used to build lipids, the enzyme sits at a critical junction of central carbon metabolism. Most of what is known about aldolase comes from medical research, particularly cancer biology, where studies have shown that blocking aldolase can push glucose-6-phosphate into the pentose phosphate pathway, increasing the production of NADPH, the reducing power that cells use for biosynthesis. The Xiamen University team, led by Yiting Zhang and Xueping Ling, asked whether the same logic could be applied to a microbe whose entire commercial value depends on how much reducing power and carbon skeleton it can pour into fatty acid synthesis.

To find out, the researchers constructed a knockout strain by replacing the aldolase gene, designated ALDOA, with a bleomycin resistance cassette through homologous recombination. They amplified roughly 420-base-pair sequences flanking the gene, ligated them into the pBlue-zeo plasmid around the resistance marker, and introduced the construct into wild-type cells by electroporation. Transformants were selected on plates containing 50 milligrams per liter of bleomycin, and PCR sequencing of the homologous arms confirmed that the native gene had been successfully replaced. The resulting strain, called ΔALDOA, was then compared with the wild type over a 168-hour shake-flask fermentation using glucose-based medium.

The immediate consequences of the deletion were negative for bulk productivity. Final biomass in the knockout strain was 9.6 percent lower than the wild-type maximum, and total lipid production fell by 23.2 percent. During active growth the deficits were even larger: at 96 hours the mutant’s cell dry weight was up to 40.61 percent below the wild type, and at 72 hours its lipid yield lagged by as much as 49.34 percent. Glucose consumption told a similar story. The wild-type strain essentially exhausted the sugar supply by 120 hours, whereas the knockout had used only about half of it at that point and needed until 168 hours to finish. Intriguingly, the mutant actually consumed glucose faster than the wild type in the earliest phase of cultivation, apparently ramping up overall metabolism to compensate for the metabolic bottleneck, before its impaired glycolysis caught up with it in the middle and later stages.

The fatty acid composition, however, moved in a very different direction. At 120 hours the proportion of saturated fatty acids in the knockout strain was about 17.4 percent lower than in the wild type, driven mainly by reductions in the C16:0 and C14:0 species. Polyunsaturated fatty acids, including DHA, docosapentaenoic acid, and eicosapentaenoic acid, rose by 28.0 percent overall, with DHA itself up 22.9 percent and EPA up a remarkable 75.0 percent. When the team broke the lipid pool down into triglycerides and phospholipids, they found that polyunsaturated fatty acids are mostly stored in triglycerides, at 35 to 48 percent of that fraction, while phospholipids carry 10 to 15 percent and contain no detectable EPA at all. The knockout boosted the polyunsaturated content of triglycerides specifically, with DHA rising 27.4 percent at 72 hours and 20.8 percent at 120 hours, while the main saturated species, C16:0, dropped by 46.5 percent and 36.0 percent at the same time points.

Phospholipidomics provided a mechanistic explanation rooted in how DHA travels through the cell. Phosphatidylcholine, the most abundant phospholipid in Schizochytrium at roughly half of the total, is known to be the first docking site for newly synthesized DHA before the fatty acid is transferred to triglycerides for storage. In the knockout strain, the proportion of phosphatidylcholine was 11.5 percent higher than the wild type at 72 hours and 7.5 percent higher at 120 hours, and lysophosphatidylcholine, its precursor in the glycerophosphorylcholine acylation pathway, reached 4.8 times the control level at 72 hours. Meanwhile, phosphatidylglycerol, a phospholipid tied to cell growth, collapsed by 92.2 percent at 72 hours, and phosphatidylinositol, phosphatidylserine, and phosphatidic acid all declined as well. Because these species are built through the Kennedy pathway from dihydroxyacetone phosphate-derived precursors, their depletion directly reflects the loss of aldolase activity upstream.

Gene expression analysis reinforced the picture. Transcripts of the fatty acid synthase gene, which produces saturated fatty acids, fell in the mutant, while the chain length factor gene of the anaerobic polyketide synthase cluster, responsible for elongating polyunsaturated chains, rose sharply in the middle and later stages of fermentation. The gene for glucose-6-phosphate dehydrogenase, the gateway enzyme of the pentose phosphate pathway, followed a similar pattern, indicating enhanced flux through that route and a greater supply of NADPH for fatty acid desaturation and elongation. Transcripts of phosphatidic acid phosphatase and diacylglycerol acyltransferase, the enzymes that convert phosphatidic acid into triglycerides via the Kennedy pathway, decreased, whereas the genes for phospholipid diacylglycerol choline phosphate transferase, or PDAT, and lysophosphatidylcholine acyltransferase, or LPCAT, were strongly upregulated. Together these shifts suggest the mutant builds its triglycerides increasingly through the phosphatidylcholine route, shuttling DHA from phospholipid storage into neutral lipid reserves.

Metabolomics by gas chromatography-mass spectrometry identified 35 differential metabolites that mapped the rewiring across glycolysis, the tricarboxylic acid cycle, the pentose phosphate pathway, and amino acid and sterol synthesis. Sugar alcohols associated with the oxidative pentose phosphate route surged, with arabitol up 4.06-fold and ribitol up 7.84-fold at 120 hours. The knockout strain also accumulated protective metabolites: inositol, a signaling molecule against oxidative stress, rose threefold, and mannitol, a hydroxyl radical scavenger, increased 1.23-fold, while glycine rose to supply precursors for glutathione synthesis. Flow cytometry using a fluorescent probe confirmed that reactive oxygen species were lower in the mutant at both measured time points. Since polyunsaturated fatty acids are vulnerable to free-radical oxidation, the reduced oxidative environment plausibly helps preserve the DHA the cells do make, complementing the increased reducing power available for synthesizing it in the first place.

The authors propose a coherent metabolic model: deleting ALDOA weakens glycolysis and the TCA cycle, slowing growth, and starves the Kennedy pathway of dihydroxyacetone phosphate, cutting total lipid and phospholipid output. In compensation, carbon is pushed into the pentose phosphate pathway, raising NADPH for polyunsaturated fatty acid synthesis, while the cell reinforces the glycerophosphorylcholine acylation route and PDAT-mediated transfer so that more DHA is bound to phosphatidylcholine and then moved into triglycerides. The trade-off is clear, with less biomass but a richer omega-3 profile per cell. The team notes that future work using CRISPR or RNA interference to tune, rather than abolish, aldolase expression could improve DHA accumulation without the growth penalty, offering a new metabolic engineering strategy for one of the world’s most important microbial oil producers.

Subject of Research: Aldolase gene disruption and carbon flux redistribution for DHA synthesis in Schizochytrium

Article Title: Functions of aldolase in lipid synthesis of Schizochytrium sp. by gene disruption to switch carbon metabolism

Article References: Zhang, Y., Wu, X., Guo, X., Li, K., Lu, Y., Lin, X., & Ling, X. (2024). Functions of aldolase in lipid synthesis of Schizochytrium sp. by gene disruption to switch carbon metabolism. Blue Biotechnology, 1(1), Article 17. https://doi.org/10.1186/s44315-024-00014-6

Image Credits: AI Generated

DOI: 10.1186/s44315-024-00014-6

Keywords: Schizochytrium, aldolase, DHA, polyunsaturated fatty acids, glycolysis, pentose phosphate pathway, carbon flux, metabolic engineering, phospholipids, triglycerides, NADPH, marine biotechnology

The research focused on the blunt snout bream (Megalobrama amblycephala), an economically important omnivorous freshwater fish farmed widely in China, and the Chinese perch (Siniperca chuatsa), a carnivorous predator from a different family. By exposing bream eggs to perch sperm, the team produced natural gynogenetic blunt snout bream, abbreviated GBSB. Because gynogenesis normally blocks the paternal genome, these offspring carry essentially maternal genetics. Yet the researchers suspected that the heterologous sperm, the sperm of a different species, might still influence early developmental events, and that these influences could cascade into differences in physiology, digestion, and the gut microbiome that persist into later life.

To test this idea, the team collected intestinal tissues from the gynogenetic bream, from normal blunt snout bream, and from both parental species. They then applied a battery of complementary techniques: metagenomic sequencing to catalogue the gut microbial communities and their functional genes, histological examination to inspect gut structure under the microscope, enzyme activity assays to measure digestive and antioxidant capacity, and quantitative gene expression analysis to track the activity of key metabolic genes. Finally, Pearson correlation analysis was used to link the abundance of microbial functions with the expression levels of host metabolic genes, providing a statistical bridge between the microbiome and the fish’s own biochemistry.

The first striking result concerned digestive performance. The intestines of the gynogenetic bream showed higher activity of several digestive enzymes than those of normal blunt snout bream, including alkaline xylanase, acid phosphatase, and lipase. These enzymes break down plant fibers, phosphorus-containing compounds, and fats respectively, and elevated activity suggests the gynogenetic fish were better equipped to extract energy and nutrients from their food. The gynogenetic fish also displayed stronger antioxidant defenses, with higher levels of catalase activity and reduced glutathione, molecules that protect tissues from the damaging reactive oxygen species generated during normal metabolism and stress.

Metabolic gene expression told a subtler story. In the gynogenetic bream, the expression of glycolysis-related genes, including GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and Idha (isocitrate dehydrogenase alpha), was downregulated compared with the maternal line. Glycolysis is the classic first step of glucose breakdown, converting sugar into pyruvate for energy. In contrast, genes of the pentose phosphate pathway, Pgd (phosphogluconate dehydrogenase) and Taldo1 (transaldolase 1), were upregulated. The pentose phosphate pathway is a parallel glucose-processing route that generates NADPH, a reducing agent crucial for antioxidant defense and biosynthesis, along with ribose sugars for DNA and RNA production. This shift suggests the gynogenetic fish may be channeling glucose away from straightforward energy production and toward cellular maintenance and protection, consistent with their elevated antioxidant capacity.

The gut microbiota analysis revealed a pattern of both continuity and change. Overall, the microbial community in the gynogenetic bream closely resembled that of the maternal parent, with the genus Bacillus dominating in both. This maternal inheritance of gut microbes is not surprising, since gynogenetic offspring develop from maternal eggs and are reared in similar environments, and gut microbiota in fish is shaped heavily by diet, environment, and vertical transmission. However, the researchers did detect shifts within two major bacterial phyla, Bacteroidota and Pseudomonadota, indicating that the gynogenetic process was not without microbial consequences. These phyla include many species involved in carbohydrate fermentation and the production of short-chain fatty acids, metabolites that feed the gut lining and influence host metabolism.

Perhaps the most intriguing finding came from the correlation analysis linking microbial functions to host gene expression. The data suggested that the heterologous sperm induction altered host gene expression, and that these changes in the host in turn drove a restructuring of the gut microbiota through host-microbiota interactions in sugar metabolism. In other words, even though the perch sperm contributed no genes to the offspring’s genome, its role in triggering development appears to have set off a chain of physiological adjustments in the fish, and those adjustments selected for a somewhat different community of gut microbes. This host-first model, in which the animal’s own metabolic state shapes which microbes thrive, offers a mechanistic explanation for how a purely maternal genome can end up with a subtly different microbiome than its mother.

The broader significance of the work lies in aquaculture. Gynogenesis is a valuable tool for fish breeders because it rapidly produces highly inbred, nearly homozygous lines, which can then be used to create hybrid vigor or fixed desirable traits. Blunt snout bream is a cornerstone species of Chinese freshwater aquaculture, and improving its digestion, growth efficiency, and disease resistance has direct economic value. The finding that microhybridization can enhance digestive enzyme activity and antioxidant capacity suggests that gynogenetic lines may carry practical advantages, but also that their altered glucose metabolism means feeding strategies designed for ordinary bream may not be optimal for gynogenetic stock. The authors note that these host metabolism-microbiota dynamics are crucial for optimizing feeding strategies and health management in novel gynogenetic fish breeds.

The study also fills a genuine gap in the scientific literature. Although gut microbiota is recognized as a critical player in host nutrition and metabolism across the animal kingdom, research on the intestinal physiology and microbiomes of gynogenetic offspring, particularly those produced by crossing an omnivorous mother with a carnivorous father, has been scarce. By combining metagenomics, histology, enzymology, and gene expression profiling in a single comparative framework spanning three fish types, the Hunan Normal University team, led by corresponding authors Ping Wu, Qizhi Liu, and Shaojun Liu, has provided one of the most complete pictures to date of how gynogenesis reverberates through the gut axis of a farmed fish.

Looking ahead, the work raises questions that extend well beyond bream. If the mere act of fertilization by foreign sperm can shift host metabolism and microbiome composition in gynogenetic offspring, similar effects might operate in other systems where interspecific sperm exposure occurs, including hybridization events in wild fish populations and assisted reproduction techniques in conservation programs. The interplay between the pentose phosphate pathway, antioxidant defenses, and microbial community structure also mirrors themes familiar from human metabolic research, where gut microbes and host glucose handling are tightly intertwined. For now, the gynogenetic bream stands as a vivid example that reproduction is more than genetics: the cellular drama of fertilization itself can echo through the gut, the microbiome, and the metabolic machinery of an entire organism.

Subject of Research: Effects of microhybridization on gut microbiota and glucose metabolism in gynogenetic blunt snout bream

Article Title: Microhybridization enhances intestinal microbiota and glycometabolic regulation in natural gynogenic blunt snout bream derived from the blunt snout bream (Megalobrama amblycephala, ♀) × Chinese perch (Siniperca chuatsi, ♂)

Article References: Wei, Y., Dai, R., Hu, M., Lei, S., Tang, J., Weng, S., Zeng, Y., Ding, Y., Qin, Q., Yi, T., Wang, M., Tao, M., Zhang, C., Wu, P., Liu, Q., & Liu, S. (2026). Microhybridization enhances intestinal microbiota and glycometabolic regulation in natural gynogenic blunt snout bream derived from the blunt snout bream (Megalobrama amblycephala, ♀) × Chinese perch (Siniperca chuatsi, ♂). BMC Genomics. https://doi.org/10.1186/s12864-026-13359-6

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13359-6

Keywords: gynogenesis, microhybridization, gut microbiota, blunt snout bream, Chinese perch, glucose metabolism, glycolysis, pentose phosphate pathway, digestive enzymes, aquaculture, host-microbe interactions, metagenomics

Plants do not surrender to fungal invasion without a fight. One of the earliest and most potent weapons in their innate immune arsenal is the oxidative burst, a rapid accumulation of reactive oxygen species, or ROS, at the site of infection. Hydrogen peroxide, the central player in this response, oxidatively damages fungal DNA, proteins, and lipid membranes while also restricting the nutrients available to the pathogen. ROS additionally act as signaling molecules that switch on defense-related genes throughout the plant. To counter this assault, fungal pathogens deploy an array of antioxidant enzymes, including catalases, peroxidases, and superoxide dismutases, alongside non-enzymatic reducing agents such as NADPH and glutathione, the most abundant intracellular thiol, which buffers the cell’s redox state and donates electrons to neutralize ROS.

The connection between sugar metabolism and this antioxidant machinery lies in the pentose phosphate pathway, the major source of NADPH in the cell. NADPH supplies the reducing equivalents that allow glutathione reductase to recycle oxidized glutathione back to its active form, sustaining the redox cycle that keeps ROS in check. In fungi such as the rice blast pathogen Magnaporthe oryzae and the yeast Saccharomyces cerevisiae, the trehalose 6-phosphate synthase Tps1 acts as a metabolic sensor for glucose-6-phosphate and regulates NADPH production through the pathway. ABL1, a gene encoding a protein resembling the beta subunit of AMP-activated protein kinase, was previously identified as a downstream component of this glucose-sensing circuit in M. oryzae. Whether an equivalent regulator governed the metabolism and virulence of C. chrysosperma was, until now, unknown.

Using protein sequence comparisons, the team identified a single Abl1 homolog in C. chrysosperma, designated CcAbl1, and found that related proteins are highly conserved across diverse filamentous fungi. Expression analysis showed that CcAbl1 is strongly glucose-responsive: in shake culture, its transcript levels rose roughly ninefold when glucose was added to the medium. During infection of poplar leaves, the gene was expressed at low levels one day after inoculation but became significantly upregulated by day three, a timing that suggested it participates in the early proliferation of the fungus inside host tissue.

To test its function directly, the researchers generated a deletion mutant lacking the entire CcAbl1 open reading frame, along with a genetically complemented strain in which the gene was restored. Pathogenicity assays on poplar branches told a striking story. Seven days after inoculation, the mutant produced markedly smaller necrotic lesions than the wild-type and complemented strains. Trypan blue staining of infected leaves revealed a greatly diminished ability of the mutant to induce host cell death, and quantitative PCR measurements of fungal biomass from one to six days post-infection showed that the mutant consistently accumulated far less tissue than either control strain. CcAbl1, the authors concluded, is essential for virulence.

The metabolic basis of this defect emerged from a series of growth experiments and metabolomic analyses. On minimal medium containing ten percent glucose, the wild-type and complemented strains grew robustly, while the deletion mutant showed pronounced growth defects, a phenotype that was much weaker on non-preferred carbon sources such as sucrose and cellulose. When glucose concentrations were varied from zero to twenty percent, wild-type colony growth peaked at five percent glucose, whereas the mutant faltered at five percent and above. Targeted glucose metabolomics using liquid chromatography-mass spectrometry, performed with five biological replicates per strain, revealed sharply segregated metabolic profiles: eighteen of twenty-seven detected metabolites differed significantly between the mutant and the wild type, with fourteen markedly reduced. Most of the depleted metabolites belonged to central energy metabolism and antioxidant defense pathways, and NADPH was the single most dramatically diminished metabolite in the mutant.

Because NADPH also fuels amino acid biosynthesis and nitrogen assimilation, the team examined how the mutant handled amino acids supplied as sole nitrogen sources. Wild-type hyphae grew significantly better on medium supplemented with cysteine, glutamic acid, glycine, alanine, or lysine, but the mutant failed to benefit. This was a telling result, since cysteine, glutamic acid, and glycine are the direct substrates for glutathione biosynthesis. Quantification confirmed the suspicion: total intracellular glutathione was significantly lower in the mutant under both standard culture conditions and infection-mimicking conditions using poplar branch extract, and the gap widened further under hydrogen peroxide stress. Transcript analysis of the glutathione biosynthetic genes CcGsh1 and CcGsh2, which encode gamma-glutamylcysteine synthetase and glutathione synthetase, showed that their expression was significantly reduced in the mutant under infection-mimicking conditions, and that the oxidative-stress-responsive induction of both genes seen in the wild type was substantially attenuated in the mutant.

The consequences for stress tolerance were comprehensive. The deletion mutant was hypersensitive to hydrogen peroxide and to methyl methanesulfonate, a DNA-damaging agent, and supplementing the medium with reduced glutathione partially alleviated these growth defects. Enzyme assays added a spatial dimension to the picture: intracellular catalase and superoxide dismutase activities were comparable across strains, but peroxidase activity was significantly reduced in the mutant, and under oxidative challenge the mutant showed markedly decreased extracellular catalase and superoxide dismutase activities. The authors interpret this as evidence that CcAbl1 governs antioxidant capacity principally through extracellular ROS-scavenging enzymes, while intracellular ROS removal depends predominantly on the glutathione-dependent pathway that collapses when NADPH runs short.

Perhaps the most compelling experiments concerned the host side of the interaction. When poplar leaves were infected with the mutant, DAB staining revealed significantly stronger ROS bursts than with the wild type, and defense-related genes, including the pathogenesis-related genes PR1 and PR3 and the signaling regulator MAPK6, were consistently upregulated. The team then asked whether the mutant’s weakness stemmed specifically from its inability to withstand host-derived oxidants. Pretreating host tissues with ethanol, which kills host cells and disrupts ROS generation, restored the mutant’s pathogenicity to nearly wild-type levels. Similarly, pharmacological inhibition of the host NADPH oxidase with diphenyleneiodonium reduced hydrogen peroxide accumulation in infected tissues and partially rescued mutant virulence. Together, these results directly tie the mutant’s attenuated disease capability to its heightened sensitivity to plant-generated oxidative stress.

The study establishes CcAbl1 as a central regulatory node that integrates glucose sensing, pentose phosphate pathway flux, NADPH-dependent glutathione metabolism, and oxidative stress tolerance into a single virulence program. Beyond its mechanistic significance for fungal physiology, the work carries practical implications: poplar Cytospora canker and related fungal diseases of economically important trees and crops might be controlled by targeting the metabolic-redox interface that pathogens rely upon to disarm plant immunity. As necrotrophic fungi are increasingly shown to harness sugar metabolism to fuel their antioxidant arsenals, the glucose-responsive NADPH-glutathione system identified here offers both a conceptual framework and a potential vulnerability in the arms race between trees and their fungal pathogens.

Subject of Research: Glucose-responsive regulation of NADPH-glutathione redox homeostasis and virulence in the poplar canker fungus Cytospora chrysosperma

Article Title: CcAbl1 is required for virulence via regulating NADPH–glutathione-mediated redox balance in Cytospora chrysosperma

Article References: Song, W., Guo, R., Zhou, J., & Wang, Y. (2026). CcAbl1 is required for virulence via regulating NADPH–glutathione-mediated redox balance in Cytospora chrysosperma. Stress Biology, 6(1), Article 33. https://doi.org/10.1007/s44154-026-00302-8

Image Credits: AI Generated

DOI: 10.1007/s44154-026-00302-8

Keywords: Cytospora chrysosperma, CcAbl1, NADPH, glutathione, redox homeostasis, reactive oxygen species, pentose phosphate pathway, fungal virulence, poplar canker, oxidative stress, plant immunity, carbohydrate metabolism

Researchers led by Ming Chen and Chenling Qu tracked two rice varieties—a japonica cultivar called Jinjingyou and an indica cultivar called C-liangyou Simiao—through 360 days of storage under three regimes. One group sat in conventional storage at 25 degrees Celsius and 65 percent relative humidity. A second group received 99 percent nitrogen for 40 days before re-aeration, a protocol designed to mirror the industry standard for rapid pest eradication. A third received 95 percent nitrogen for 180 days, matching the long-term pest suppression guideline from the Chinese standard LS/T 1225–2022. After the nitrogen phase, both treated groups were returned to ordinary air for the remainder of the year-long experiment.

The warning signs emerged at the end of storage. Freshness, measured by a bromothymol blue assay that tracks the acidic substances that accumulate as rice ages, fell significantly below conventional-storage levels in both nitrogen-treated groups by day 360. Germination rate, a proxy for the biological vigor of the embryo, dropped in parallel. The energy chemistry inside the kernels told the same story: ATP content and the cellular energy charge were significantly depleted in the re-aerated rice, while AMP accumulated, a signature of an energy-starved cell scrambling to stay functional.

To understand why, the team zeroed in on central carbon metabolism—the interconnected network of glycolysis, the tricarboxylic acid cycle, the mitochondrial electron transport chain, and the pentose phosphate pathway that converts stored starch into energy and building blocks. Even after harvest, rice kernels remain alive, burning through their own reserves to maintain basic physiology. The researchers measured the activities of seven key enzymes that gate the flow of carbon through this network, from hexokinase at the entry point of glycolysis to ATP synthase at the final step of mitochondrial energy production.

The enzyme data revealed a striking pattern of collapse. By day 360, mitochondrial isocitrate dehydrogenase, a rate-limiting enzyme of the TCA cycle, and ATP synthase, the core engine of oxidative phosphorylation, were both significantly suppressed in the re-aerated rice compared with conventional storage. The pentose phosphate pathway enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase were also significantly down, cutting the grain’s supply of NADPH, the reducing power that fuels antioxidant defense and nucleotide synthesis. Glycolytic enzymes showed dramatic fluctuations rather than the slow, stable decline seen in untreated rice, suggesting the treated grain was lurching through cycles of metabolic stress and partial recovery.

The most likely culprit, the authors suggest, is a phenomenon well known in plant physiology: the hypoxia–reoxygenation response. When plant tissues are deprived of oxygen and then suddenly re-exposed, reactive oxygen species surge, damaging mitochondrial membranes and inhibiting the very enzymes that generate cellular energy. The transient spike in isocitrate dehydrogenase and ATP synthase activity observed in the high-nitrogen group between days 40 and 180 fits this picture—a stress-repair response firing up when the air returned, followed by progressive exhaustion as the damage accumulated over the remaining months of storage.

Targeted metabolomics using UHPLC-MS/MS added molecular precision to the picture. Of 140 targeted metabolites, 95 passed quality filtering, and principal component and discriminant analyses cleanly separated the re-aerated rice from conventionally stored grain in both varieties. Five metabolites emerged as biomarkers of the accelerated decline. In the high-nitrogen group, fructose-6-phosphate, guanosine monophosphate, and AMP accumulated while cytosine was depleted—evidence of a traffic jam in glycolysis, disrupted nucleotide metabolism, and impaired capacity for DNA repair. In the low-nitrogen group, homogentisic acid, a precursor of the antioxidants tocopherol and plastoquinone, dropped sharply, signaling a weakened antioxidant shield.

The accumulation of fructose-6-phosphate is particularly telling. This glycolytic intermediate piled up in both varieties under the high-nitrogen protocol, likely because phosphofructokinase, the enzyme that should consume it downstream, was significantly inhibited. A stalled pipeline means less carbon flowing toward ATP production and fewer carbon skeletons for biosynthesis, a metabolic bottleneck that echoes findings in cold-stressed peas and nitrogen-starved apple roots, where fructose-6-phosphate likewise accumulates under duress.

The practical implications are immediate. Nitrogen treatment still does its job during the sealed phase—freshness was actually better preserved at day 180 in the long-nitrogen group than in conventional storage—but the benefits evaporate, and then reverse, once the grain meets ordinary air. The authors recommend that paddy rice be processed and consumed promptly after re-aeration rather than returned to long-term storage. They also point to possible remedies: gradual re-aeration to soften the oxidative burst, or exogenous metabolic regulators to restore carbon flux through the compromised pathways.

Caveats remain. The experiment was conducted under tightly controlled laboratory conditions of constant temperature and humidity, and the authors note that verification in real warehouses with full-scale nitrogen systems and longer storage horizons is still needed. Even so, the study reframes a technology often assumed to be purely protective. The nitrogen atmosphere, it turns out, does not simply pause the life of the grain—it reshapes its metabolism in ways that only become costly when the air comes back.

Subject of Research: Effects of nitrogen-modified atmosphere storage and re-aeration on central carbon metabolism and quality deterioration in stored paddy rice

Article Title: Nitrogen-modified atmosphere with re-aeration storage triggers deterioration in paddy rice by disrupting central carbon metabolism

Article References: Chen, M., Xue, F., Li, M., Liu, X., Zhang, Y., & Qu, C. (2026). Nitrogen-modified atmosphere with re-aeration storage triggers deterioration in paddy rice by disrupting central carbon metabolism. Food Chemistry: X, 39, Article 104524. https://doi.org/10.1016/j.fochx.2026.104524

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104524

Keywords: paddy rice, nitrogen-modified atmosphere storage, re-aeration, central carbon metabolism, glycolysis, TCA cycle, pentose phosphate pathway, ATP synthase, targeted metabolomics, grain storage quality, oxidative stress, seed germination

The review, authored by Yuefan Zhang, Yan Zhang, Shuo Xia, Aamer Ali Shah, Rui Zhang and corresponding author Chunjie Gong of Hubei University of Technology and collaborating institutions, arrives at a moment when demand for xylitol is climbing alongside the global rise in diabetes. Unlike sucrose, xylitol delivers sweetness with a low glycemic impact, and decades of research have linked it to benefits ranging from cavity prevention to possible roles in respiratory health, skin barrier function and gut microbiome modulation. But producing it at industrial scale remains expensive, and the new analysis argues that the answer lies not in better chemistry but in smarter biology.

At the heart of the biological route is a single enzymatic step. Xylose, a five-carbon sugar abundant in hemicellulose from agricultural waste such as corncobs, sugarcane bagasse, wheat straw and rice straw, is reduced to xylitol by the enzyme xylose reductase. In nature, yeasts such as Candida tropicalis, Candida guilliermondii, Debaryomyces hansenii and Yarrowia lipolytica perform this conversion, and bacteria including Enterobacter species and engineered Escherichia coli can be coaxed to do the same. The catch is that the reaction consumes reduced nicotinamide cofactors, NADH or NADPH, which the cell must continuously regenerate. When cofactor supply runs dry, production stalls, and unwanted byproducts accumulate as the microbe reroutes carbon elsewhere.

This cofactor bottleneck is precisely where modern metabolic engineering has made its mark. The review details how researchers have rebuilt xylitol pathways from the ground up: overexpressing xylose reductase, deleting xylitol dehydrogenase so the product cannot be consumed again, and rewiring the pentose phosphate pathway to pump out the NADPH the reductase demands. In engineered E. coli, teams have multiplied copies of the xylose reductase gene while deleting genes of the Embden-Meyerhof-Parnas glycolytic route, forcing carbon flux toward NADPH regeneration and sharply improving yields. Similar logic has been applied in yeasts, where co-expression of pentose phosphate pathway genes in Candida tropicalis boosted xylitol titers, and disruption of the xylitol dehydrogenase gene under fully aerobic conditions raised both productivity and yield.

Beyond single-gene interventions, the field has embraced modular design. Rather than tweaking one enzyme at a time, synthetic biologists now assemble pathway modules that can be independently tuned, balancing expression strengths through choices of promoters and ribosome binding sites. Dynamic control systems add another layer of sophistication: in engineered E. coli, researchers have placed feedback regulatory loops under programmable control, improving NADPH flux and xylitol biosynthesis simultaneously. Cofactor engineering has even extended to redesigning the coenzyme specificity of central metabolic enzymes, a strategy proven in other products and increasingly relevant to xylitol, where the balance between NADH and NADPH dictates how much reducing power is available for the key reductive step.

Choice of host organism matters as much as pathway design. The review weighs the trade-offs among industrial chassis cells: natural xylose-fermenting yeasts like Candida and Debaryomyces species are robust on lignocellulosic hydrolysates but may not be food-grade; the baker’s yeast Saccharomyces cerevisiae is Generally Recognized As Safe and genetically tractable but needs extensive engineering to consume xylose efficiently; E. coli grows fast and tolerates manipulation but raises regulatory hurdles for food applications. Thermotolerant hosts such as Kluyveromyces marxianus offer the bonus of high-temperature fermentation, cutting cooling costs, while oleaginous yeasts like Yarrowia lipolytica can co-consume crude glycerol and xylose, turning two waste streams into one product. Even filamentous fungi have entered the arena, with engineered Neurospora crassa producing xylitol from xylose and Aspergillus niger converting L-arabinose into the sweetener.

Feedstock strategy is evolving in parallel. Hemicellulosic hydrolysates from corncob, sugarcane bagasse, wheat straw, rapeseed straw and even banana peel provide cheap xylose, but they carry inhibitors, furans and acids, that poison fermentation, requiring detoxification steps. Recent work has explored co-substrate models that pair xylose with other sugars to sustain cofactor regeneration, and a striking new mode uses the microalga Chlorella sorokiniana driven synergistically by light and co-substrates to biosynthesize xylitol, hinting at photosynthesis-assisted production. Adaptive laboratory evolution, in which strains are bred for tolerance to hydrolysate toxins over many generations, rounds out the toolkit for making industrial feedstocks usable.

The most forward-looking section of the review concerns artificial intelligence. Machine learning models, from artificial neural networks and support vector regression to deep neural networks, are already predicting fermentation outcomes and optimizing bioreactor parameters, with early demonstrations coupling neural networks to genetic algorithms to maximize xylitol production by Debaryomyces nepalensis. Protein language models and structure-prediction systems of the AlphaFold era now allow researchers to forecast enzyme properties and steer directed evolution of xylose reductases toward higher activity and better cofactor preference, while deep learning tools navigate biosynthetic pathways for natural products. Genome-scale metabolic models fused with machine learning can characterize cell growth from multi-omics data, and multimodal networks promise to integrate fermentation time-courses with transcriptomic and flux information into unified predictive frameworks.

All of this feeds into what the authors describe as a closed-loop design-build-test-learn cycle. In this framework, AI predicts metabolic network behavior and proposes enzyme variants; automated construction builds the strains; high-throughput testing measures performance; and the results are fed back to refine the models. Computational fluid dynamics and process modeling extend the loop from the cell to the bioreactor, while techno-economic and sustainability analyses, including assessments of xylitol production within integrated biorefinery platforms aimed at circular economies, evaluate whether bio-xylitol can compete with petrochemical and catalytic hydrogenation routes on cost and carbon footprint.

The review is candid about remaining obstacles: enzymatic bottlenecks, carbon flux imbalances, feedstock variability, downstream purification costs and the regulatory demands of food-grade production all persist. It also notes that the health conversation around xylitol is not settled, with recent research reporting potential prothrombotic associations that warrant attention even as dental and metabolic benefits remain well documented. Still, the authors conclude that the convergence of rational metabolic engineering, food-grade chassis optimization and AI-guided bioprocessing provides a comprehensive blueprint for making microbial xylitol economically viable. If the design-build-test-learn loop matures as its proponents hope, the sweetener in sugar-free gum and diabetic-friendly foods may soon come from fermentation tanks where algorithms, not just chemists, decide what the microbes make next.

Subject of Research: Metabolic engineering and AI-driven bioprocessing of microbial cell factories for xylitol production

Article Title: Advances in microbial cell factories for substitute sugar xylitol production: from metabolic engineering to AI-driven bioprocessing

Article References: Zhang, Y., Zhang, Y., Xia, S., Shah, A. A., Zhang, R., & Gong, C. (2026). Advances in microbial cell factories for substitute sugar xylitol production: from metabolic engineering to AI-driven bioprocessing. 3 Biotech, 16(10), Article 427. https://doi.org/10.1007/s13205-026-05072-8

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05072-8

Keywords: xylitol, metabolic engineering, microbial cell factories, xylose reductase, cofactor engineering, synthetic biology, artificial intelligence, bioprocessing, lignocellulosic biomass, sugar substitute, pentose phosphate pathway, industrial biotechnology

The technical centerpiece of the work is a family of fluorescent biosensors called iNap, which fluoresce in proportion to NADPH concentration and can be targeted to specific cellular compartments. When the researchers expressed these sensors in adult mouse cardiomyocytes, they observed that swimming and running exercise elevated the NADPH signal in the cytosol while leaving the mitochondrial pool untouched. This compartmental specificity matters, because cytosolic and mitochondrial NADPH fluxes are known to be independently regulated, and it points the finger away from mitochondrial transhydrogenase and toward cytosolic sources. Among those sources, the pentose phosphate pathway, or PPP, stood out: a glucose-shunting branch of metabolism whose rate-limiting enzyme, glucose-6-phosphate dehydrogenase (G6PD), strips electrons from glucose-6-phosphate and deposits them onto NADP+ to make NADPH.

The causal chain was established through a series of loss-of-function experiments. When the team inhibited PPP activity or depleted cytosolic NADPH in mice, the heart’s response to exercise was blunted: the characteristic enlargement of cardiomyocytes that normally accompanies training failed to materialize. Conversely, the study showed that NADPH itself is a driver of cardiomyocyte growth, acting by inhibiting the HDAC3/C/EBPβ pathway—a signaling axis previously implicated in the control of exercise-induced cardiac growth. In other words, the reducing equivalents manufactured by the PPP do more than keep reactive oxygen species in check; they directly tune an epigenetic and transcriptional program that tells heart cells to grow in a coordinated, physiological manner rather than in the maladaptive fashion seen in disease.

The protective side of the story emerged from mouse models of acute ischemia–reperfusion injury, a scenario that unfolds in millions of patients each year when a blocked coronary artery is reopened and the sudden return of oxygen floods the tissue with reactive oxygen species. Mice with an exercise-activated PPP/NADPH pathway suffered measurably less injury from a subsequent ischemia–reperfusion challenge, and this protection persisted: four weeks after the insult, heart function remained significantly preserved compared with sedentary controls. The mechanism appears to be twofold. First, abundant NADPH sustains the glutathione and thioredoxin antioxidant systems that neutralize the oxidative burst of reperfusion. Second, by suppressing HDAC3 activity, NADPH restrains the transcriptional changes that push stressed cardiomyocytes toward death and maladaptive remodeling.

What makes the study more than an elegant piece of mechanistic cardiology is its drug-discovery angle. The researchers screened 310 Tibetan medicinal compounds for the ability to raise intracellular NADPH, and one molecule rose to the top: lyciumspermidine-0527, a spermidine derivative derived from a plant used in traditional Tibetan medicine. Biochemical and structural analyses showed that this compound directly activates G6PD, the rate-limiting enzyme of the pentose phosphate pathway, stabilizing the enzyme’s active dimeric form. In cultured cardiomyocytes and in living mice, lyciumspermidine-0527 elevated cytosolic NADPH, promoted cardiomyocyte growth, and—most strikingly—alleviated ischemia–reperfusion injury to a degree that rivaled exercise itself.

Safety data accompanying the compound were encouraging. Across a range of doses in vitro and in vivo, lyciumspermidine-0527 did not significantly induce cell death in the heart, and histological examination of heart, liver, lung, kidney, and brain tissue showed no overt toxicity. The compound also maintained redox homeostasis in cardiomyocytes, consistent with its proposed mechanism of boosting, rather than overwhelming, the cell’s antioxidant buffering capacity. Genetic confirmation followed: when G6PD was knocked down, the protective effects of the compound vanished, placing G6PD squarely upstream of the observed benefit and ruling out major off-target explanations for the phenotype.

Conceptually, the findings reframe physiological cardiac hypertrophy as a metabolic checkpoint phenomenon. The healthy heart’s enlargement in response to exercise has long been distinguished from the pathological hypertrophy of hypertension or heart failure by its reversibility and preserved function, but the molecular gatekeepers separating the two states have been only partially mapped. By demonstrating that PPP-derived NADPH is required for exercise-induced growth and simultaneously protective against injury, the study positions a single metabolite as a checkpoint that integrates the demand for biosynthesis (NADPH feeds fatty acid and nucleotide production), antioxidant defense (NADPH powers glutathione reductase), and epigenetic regulation (NADPH inhibits the HDAC3–Ncor complex). Exercise, in this view, is a metabolic intervention, and its cardiac benefits can be recapitulated—at least in mice—by pharmacologically opening a single metabolic valve.

The translational horizon is tantalizing but cautious. Lyciumspermidine-0527 is not yet a drug, and the leap from mouse models of surgically induced ischemia–reperfusion to human myocardial infarction is considerable. G6PD activity is a double-edged sword: the same pathway that supports antioxidant defense in cardiomyocytes also supports nucleotide synthesis and growth in cancer cells, raising questions about systemic effects that would need careful evaluation in longer-term studies. Nonetheless, the identification of a small molecule that directly activates G6PD offers a starting point for medicinal chemistry, and the iNap biosensor toolkit the team deployed provides a template for screening compounds by their ability to raise NADPH in specific subcellular compartments rather than by crude proxies.

For now, the study’s most immediate contribution is conceptual clarity. It explains, in mechanistic terms, why the exercising heart grows well and withstands injury better, connecting the dots from a transcription factor (SP1-driven G6PD expression), through a metabolic flux (the pentose phosphate pathway), to a redox cofactor (cytosolic NADPH), and finally to an epigenetic effector (HDAC3/C/EBPβ) and a clinical phenotype (preserved function after reperfusion). It also validates a natural-product-inspired approach to finding exercise mimetics for the heart. If the PPP/NADPH axis holds up in larger preclinical models, the prospect of a pill that trains the heart’s metabolism—conferring some of exercise’s cardioprotection on patients who cannot exercise—moves from metaphor to plausible pipeline.

Subject of Research: Pentose phosphate pathway-derived NADPH as a metabolic checkpoint regulating exercise-induced physiological cardiac hypertrophy and protection against ischemia–reperfusion injury

Article Title: Pentose phosphate pathway-derived NADPH facilitates physiological hypertrophy and alleviates ischemia–reperfusion injury in the heart

Article References: Wu, D., Chen, T., Dong, X., Li, H., Cheng, Z., Li, H., Chao, Y., Li, F., Yin, Y., Guo, F., Xu, X., Zhang, Y., Ning, K., Fu, X., Bian, Y., Ma, F., Ritterhoff, J., Wang, W., & Hu, Q. (2026). Pentose phosphate pathway-derived NADPH facilitates physiological hypertrophy and alleviates ischemia–reperfusion injury in the heart. Nature Metabolism. https://doi.org/10.1038/s42255-026-01587-9

Image Credits: AI Generated

DOI: 10.1038/s42255-026-01587-9

Keywords: NADPH, pentose phosphate pathway, cardiac hypertrophy, exercise, ischemia-reperfusion injury, glucose-6-phosphate dehydrogenase, cardiomyocytes, HDAC3, lyciumspermidine-0527, redox homeostasis, cardiac metabolism, Nature Metabolism

The distinction between healthy and harmful heart enlargement sits at the center of the work. Cardiac hypertrophy, the thickening of heart muscle, comes in two physiologically opposite flavors. Physiological hypertrophy, triggered by exercise or pregnancy, enlarges the heart while preserving or improving its contractile function, and it is accompanied by efficient energy metabolism, robust blood vessel growth, and molecular profiles dominated by fatty acid oxidation. Pathological hypertrophy, driven by chronic hypertension, valve disease, or heart attack, produces similar gross enlargement but with stiffening walls, impaired pumping, fibrosis, metabolic inflexibility, and a march toward heart failure. Decades of research have sought the molecular switch that separates these two trajectories, and the new findings place cytosolic NADPH firmly on the protective side of that divide.

Technically, the study hinged on the ability to see and manipulate NADPH in living systems, a long-standing challenge because NADPH and its oxidized counterpart NADP+ are structurally almost identical and interconvert rapidly. Wu and colleagues combined genetic models targeting glucose-6-phosphate dehydrogenase, or G6PD, the rate-limiting enzyme of the oxidative pentose phosphate pathway and the principal cytosolic source of NADPH, with readouts of cardiac structure, function, and metabolism. When exercise-induced increases in G6PD activity were blunted, the beneficial cardiac remodeling that normally follows training was lost, demonstrating that the pathway is not merely a byproduct of exercise but a necessary component of its cardiac benefits.

The protective payoff became most apparent in models of ischemia/reperfusion injury, the cellular catastrophe that occurs when blood supply to the heart is briefly cut off and then restored, as happens during a heart attack. Animals with elevated cytosolic NADPH, whether achieved through exercise or through the spermidine-derived compound, showed improved cardiac function and reduced injury after the insult. The team traced this protection to NADPH’s established biochemical roles: the molecule is the electron donor for thioredoxin and glutathione antioxidant systems that neutralize reactive oxygen species, the corrosive byproducts of reoxygenation that kill cardiomyocytes in the minutes and hours after blood flow returns. By keeping antioxidant capacity high, elevated NADPH effectively raises the heart’s threshold for reperfusion damage.

What makes the result especially compelling is the pharmacological angle. Spermidine itself has been linked in prior studies to cardioprotection and extended healthspan, prompting interest in its derivatives as drug candidates. Wu and colleagues identified a candidate spermidine derivative that raises cytosolic NADPH and reproduces key features of the exercise phenotype: physiological growth of the heart, enhanced antioxidant buffering, and resilience to ischemic injury, without the maladaptive gene expression patterns that characterize pathological hypertrophy. In effect, the compound simulates a metabolic signature of the trained heart in sedentary animals.

The concept of an exercise-mimicking pill has long hovered at the edge of cardiovascular research, often disappointing in translation because broad interventions that mimic one aspect of exercise tend to disrupt others. The NADPH-centered approach is narrower and, its proponents argue, more principled. Rather than attempting to replicate the whole-body storm of hormones, neural signals, and mechanical loading that exercise produces, the strategy targets a single downstream metabolite that sits at a convergence point for the cardiac benefits of training. NADPH is consumed in the synthesis of reduced glutathione, regenerated by G6PD and by malic enzyme and isocitrate dehydrogenase reactions, and shuttled across compartments by dedicated transporters, making its cytosolic pool a well-positioned control point for redox homeostasis.

The study also builds on a growing appreciation that NADPH metabolism is not uniform across cellular compartments. Mitochondrial NADPH, generated by transhydrogenase and other enzymes, has distinct roles in antioxidant defense and biosynthesis, while nuclear and cytosolic pools feed separate redox circuits. By focusing specifically on the cytosolic compartment and linking it to G6PD flux, the work offers a more precise target than earlier, cruder attempts to boost cellular reduction potential. Fluorescent biosensors that distinguish NADPH from NADH, developed in recent years, made the compartment-specific measurements feasible and are likely to accelerate follow-up studies in other tissues where NADPH balance governs immune function, fat metabolism, and aging.

Important caveats remain before the findings can inform human medicine. The work was conducted in animal models, and the dose, safety, and long-term consequences of chronically elevating cytosolic NADPH are unknown. Excessive NADPH generation has been implicated in other contexts in fueling proliferative signaling and in providing reducing equivalents to NADPH oxidases, which produce the very reactive oxygen species the heart must defend against. The authors and commentators, including Bryce J. Carpenter and Pieterjan Dierickx of the Max Planck Institute for Heart and Lung Research, who wrote an accompanying News and Views analysis, emphasize that the therapeutic window will need careful definition: the goal is the physiological range achieved by exercise, not an unbounded increase. Questions also remain about whether NADPH elevation alone can recapitulate the vascular and neuronal adaptations of exercise or whether it must be paired with other signals.

Even with those qualifications, the study reframes a central question in cardiovascular medicine. If the protective effects of exercise on the heart converge on a measurable metabolite, then patients confined to hospital beds, older adults with frailty, and the vast population that fails to meet physical activity guidelines may one day have access to a therapy that borrows the heart’s own training program. A candidate spermidine derivative that lifts cytosolic NADPH is an early but concrete step along that path, and it signals that the metabolic underpinnings of exercise’s benefits are finally becoming druggable.

Subject of Research: The role of cytosolic NADPH produced by the pentose phosphate pathway in mediating exercise-induced physiological cardiac hypertrophy and protection against ischemia/reperfusion injury.

Article Title: Increasing cytosolic NADPH to mimic exercise

Article References: Carpenter, B. J., & Dierickx, P. (2026). Increasing cytosolic NADPH to mimic exercise. Nature Metabolism, 8(9), 1827-1828. https://doi.org/10.1038/s42255-026-01580-2

Image Credits: AI Generated

DOI: 10.1038/s42255-026-01580-2

Keywords: NADPH, cardiac hypertrophy, exercise mimicry, pentose phosphate pathway, G6PD, spermidine, ischemia/reperfusion injury, heart failure, cardiac metabolism, antioxidant defense, Nature Metabolism, cardioprotection